WHO Finds Cancer Drugs “Unjustifiably” Expensive
In a 2018 report, the World Health Organization (WHO) stated that the cost of developing new cancer treatments doesn’t justify their exorbitant price tags.
“The...
Ghana Partners With Novartis to Improve Treatment Of Sickle Cell Disease
The government of Ghana is partnering with Novartis to improve diagnosis and treatment of patients with sickle cell disease (SCD). Through the public-private collaboration,...
Lawmaker Investigates Drug Pricing Practices
As congressional lawmakers continue efforts to lower drug prices, U.S. Representative Elijah Cummings (D-MD), who chairs the House Oversight and Government Reform Committee, launched...
Microsoft and Walgreens Team Up on Digital Health Care
Walgreens is teaming up with Microsoft to build up its digital health offerings. In the new, seven-year partnership, Microsoft will provide cloud services to...
Will Posting Prices Drive Down Costs of Hospital Services?
Starting this year, U.S. hospitals must comply with an executive order to post list prices of all their services “on the internet in a...
Lawmaker Introduces Bill to End Tax Breaks for Consumer Drug Ads
U.S. Senator Jeanne Shaheen (D-NH) introduced a bill (End Taxpayer Subsidies for Drug Ads Act) that would amend a 1997 guideline permitting pharmaceutical companies...
Opioid Overdose Tops List of Leading Causes of Death in the U.S.
The odds of dying from an accidental opioid overdose in the U.S. are greater than those of dying in a car accident, according to...
Increased Access to Private Care for U.S. Veterans
As part of the Mission Act of 2018, the U.S. Department of Veterans Affairs (VA) is planning to allow veterans to use their health...
Biosimilar Misinformation Campaigns Lead to Corporate Fight
U.S. Food and Drug Administration (FDA) officials are concerned that drug companies are spreading misinformation about biosimilar versions of their products, potentially undermining confidence...
A Priority for Both Parties: Lowering Drug Costs
Reining in skyrocketing pharmaceutical pricing has been a priority of the Trump administration, and lawmakers have recently ramped up efforts to introduce legislation that...
Current Issue
February 2019, Volume 5, Issue 3
This issue features a look at the unique challenges of developing treatments for orphan diseases, more coverage of the 2018 ASH annual meeting, and more.
